Immunome
Price & Volume
Stats
See more52W Range | $8.66-$30.06 |
Market Cap | $3.2B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$206.2M |
Diluted EPS | -$2.48 |
News
See moreYahoo Finance • 2 months ago
What This Immunome Sale Means a Day Before a Big FDA Milestone
Yahoo Finance • 3 months ago
What Offers Immunome (IMNM) a Compelling Investment Opportunity?
Yahoo Finance • 5 months ago
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
Yahoo Finance • 5 months ago
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch
About
CEO | Dr. Clay B. Siegall Ph.D. |
Address | 18702 North Creek Parkway, Bothell, WA, United States, 98011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 247 |